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An 11-year-old boy, who presented with abdominal pain and vomiting was noted to have a gastric
submucosal mass at endoscopy. Endoscopic ultrasound showed it arising from the fourth ultrasound
level of the gastric wall precluding endoscopic removal. Open surgery was avoided by use of endoscopic-
assisted laparoscopic surgery (EALS) to remove the mass. The mass was found to be an isolated gastric
neuroﬁbroma, a rare tumor in children. We show that combined use of intraluminal endoscopy and
laparoscopic surgery allows for safe and less-invasive surgery for removal of a submucosal mass in a
child. Further, we review the rare ﬁnding of gastric neuroﬁbromas.
 2013 The Authors. Published by Elsevier Inc. Open access under CC BY license.Submucosal gastric tumors present both a diagnostic and
therapeutic challenge for surgeons and gastroenterologists alike.
These tumors are most commonly identiﬁed as gastrointestinal
stromal tumors (GIST) or leiomyomas; more rare tumors include
leiomyosarcomas, schwannomas, and neuroﬁbromas. The thera-
peutic approach to such tumors is dependent on the type of tumor
(benign or malignant), location within the stomach, and depth
within the gastric wall from which the tumor arises. Historically,
open resection was the preferred therapeutic option, but advances
in laparoscopic surgery and therapeutic endoscopy have led to less
invasive options. Laparoscopic surgery and endoscopic resection
each offer unique advantages over the other; combining the tech-
niques offers the advantages of both procedures, a technique
referred to as endoscopic-assisted laparoscopic surgery (EALS). This
technique is well-established in adults. To date there have been no
reports of EALS for the removal of submucosal gastric tumors in
children. We report our experience with EALS for removal of a
gastric neuroﬁbroma in a child and offer a brief review gastric
neuroﬁbromas.þ1 601 815 1053.
.
Inc. Open access under CC BY license.1. Patient report
An 11-year-old male presented with a several week history of
abdominal pain and vomiting. The pain occurred daily without
identiﬁable triggering or relieving factors, persisted for hours, and
resolved spontaneously. The pain was localized to the epigastrium
but was poorly characterized; it awakened him from sleep 5 days a
week. He had associated vomiting, which was devoid of blood,
coffee-ground material, and bile. He had no fever, diarrhea, rectal
bleeding, jaundice, or weight loss. Past medical history was positive
only for hospitalization for wheezing at 6 months of age, and
incision and drainage of a suppurative lymph node at 2 years of age.
Family history was signiﬁcant for a hiatal hernia and gastroesoph-
ageal reﬂux in the father; there was no history of migraines, peptic
ulcer disease, or inﬂammatory bowel disease. Examination revealed
normal growth parameters, a normal abdominal examination, and
a rectal examination negative for occult blood. Laboratory studies to
include a complete blood count, erythrocytic sedimentation rate,
and urinalysis were normal. Hewas placed on aweight-appropriate
dose of omeprazole for 2 months, without improvement in the
abdominal pain. An upper endoscopy was performed which
showed erythema of the antrum without nodularity, erosion, or
ulceration; a rapid urease test was positive within 15 min. A 1-cm
submucosal mass with central ulceration was seen on the greater
curvature of the body of the stomach (Fig. 1); it was non-
compressible with closed biopsy forceps. Biopsies taken from the
Fig. 1. Endoscopic features of the gastric tumor. At the initial endoscopy a ﬁrm, non-
compressible mass with central ulceration was seen on the posterior wall of the
stomach.
T. Westmoreland et al. / J Ped Surg Case Reports 1 (2013) 333e336334antrum revealedmoderate active chronic gastritis with Helicobacter
pylori (Hp) organisms identiﬁed on toluidine blue-stained sections.
The patient was treated with a 2 week course of amoxicillin, clar-
ithromycin, and lansoprazole for Hp-induced gastritis and repeat
endoscopy scheduled for endoscopic ultrasound and biopsy of the
mass.
One month later the patient had resolution of his abdominal
pain, and stool for Hp antigen was negative. At repeat endoscopy
the mass was determined to arise from the fourth ultrasound level
of the gastric wall suggesting a gastrointestinal stromal tumor
(Fig. 2). Attempts at ﬁne needle biopsy were unsuccessful so a
needle knife was used to open the mucosa followed by pinch bi-
opsies of the mass. The mucosal defect was closed with endoclips.
The biopsies showed a bland spindle cell neoplasm with lack of
nuclear pleomorphism and mitotic activity within the tumor cells.
Immunohistochemical studies showed that the tumor cells were
diffusely positive for S-100 and negative for desmin, myogenin,
CD117 and CD34 supporting a diagnosis of neuroﬁbroma.Fig. 2. Endoscopic ultrasound of the gastric tumor. Endoscopic ultrasound showed that
the tumor arose from the fourth ultrasound level of the gastric mucosa representing
the muscularis propria, suggestive for a gastrointestinal stromal tumor.After discussion with the family and Pediatric Surgery, it was
decided to perform endoscopic-assisted laparoscopic removal of
the gastric mass. Following informed consent, placement of
appropriatemonitoring lines, and induction of general anesthesia, a
5-mm trocar was placed. Carbon dioxide was infused into the
abdominal cavity to a pressure of 15 mm Hg. A 30-degree laparo-
scope was introduced into the abdominal cavity. Next, three 5-mm
trocars were placed; one in the right upper quadrant and two in the
left to mid upper quadrant. The stomach was examined lapa-
roscopically, but the location of the mass could not be identiﬁed.
The pylorus was then occluded with a grasper, and an upper
endoscopy was performed showing a mass arising the on the
posterior wall of the stomach (Fig. 3). The stomach was desufﬂated,
and the short gastric arteries were taken down using a harmonic
scalpel. The stomach was then turned to expose the posterior wall.
Once again, the pylorus was occluded with a grasper, and upper
endoscopy was performed. Pressure was applied to the gastric mass
from within the stomach with biopsy forceps, and the tented-out
stomach was grasped on the serosal surface through the laparo-
scope. The stomach was then desufﬂated, and an Endo GIA60
stapler (2.5-mm load) was placed across the stomach containing
the gastric mass. Prior to deploying the stapler, the endoscope was
advanced back into the stomach to conﬁrm that the mass was
successfully captured within the portion of the stomach to be
removed. The stapler was then deployed to ligate and transect the
portion of the stomach containing the mass. The stomach specimen
was then removed through the umbilical port and submitted to
pathology.
The tumor was a ﬁrm nodule (2.0 1.51.5 cm) with ulceration
at the center (Fig. 4A), composed of interlacing bundles of bland
spindle cells with wavy nuclei admixed with ﬁbroblasts and char-
acteristic dense bundles of collagen (Fig. 4B and C). Immunohisto-
chemical studies again showed that the tumor cells were diffusely
positive for S-100 and negative for desmin, myogenin, CD117 and
CD34 conﬁrming a diagnosis of neuroﬁbroma (Fig. 4D and E).Fig. 3. Endoscopic ﬁndings at the time of surgery. At surgery, light from the laparo-
scopic illuminated the tumor. An endoclip from the previous biopsy is seen attached to
the surface of the tumor.
Fig. 4. Pathological specimen and histological ﬁndings. The tumor was identiﬁed as a
ﬁrm nodule (2.0  1.5  1.5 cm) with ulceration at the center from a previous biopsy
(A). Gastric mucosa (top) was seen overlying a well-circumscribed submucosal spindle
cell lesion (bottom) (B, H&E 2). The tumor was composed of interlacing bundles of
bland spindle cells with wavy nuclei admixed with ﬁbroblasts and characteristic dense
bundles of collagen (C, H&E, 20). The neoplastic cells were strongly positive for S100
(D, H&E, 20). CD117 failed to stain the neoplastic cells but highlighted intra-tumoral
mast cells (E, H&E, 20).
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Gastric submucosal tumors in children are a rare occurrence.
Studies in adults have shown that these tumors are most commonly
gastrointestinal stromal tumors (GIST) or leiomyomas; more rare
tumors include leiomyosarcomas, schwannomas, and neuroﬁ-
bromas. Differentiation between these tumors cannot be made
solely by endoscopic visualization. Endoscopic ultrasound (EUS) has
been used with fair success (89% sensitivity, 86% speciﬁcity, 80%
overall accuracy) in differentiating GISTs from leiomyomas [1,2].
However, the malignant potential of submucosal tumors cannot be
made with certainty by EUS, thus a deﬁnitive diagnosis requires
pathological conﬁrmation [1]. Standard forceps biopsy is inadequate
for obtaining tissue from submucosal tumors as the biopsies typi-
cally do not reach beyond themucosa.While deeper biopsies can beobtained by ﬁne needle aspiration and Tru-cut needle biopsy, the
tissue samplemakesuponlya small portionof a tumorandmaymiss
malignant cells. Excisional biopsywithadequate tumormargin is the
preferred method for gastric submucosal tumors [3,4].
Minimally invasive surgery has revolutionized the approach to
gastric tumors, highlighted by rapid advances in laparoscopic sur-
gery (LS) and therapeutic endoscopy. Prior to LS, gastric tumors
required open laparotomy. With the advent of LS and improvement
in laparoscopic instruments a number of laparoscopic techniques
have been employed for the removal of gastric wall tumors
including enucleation, transgastric tumor-everting resection,
intragastric tumor wedge resection, and extraluminal wedge
resection [3]. However, each of these techniques has drawbacks.
Enucleation of GISTs is technically successful but there is a high rate
of tumor recurrence [5]. Transgastric tumor-everting resection can
lead to intra-abdominal contamination with gastric juice, tumor
seeding, and injury to the esophago-cardiac junction [3]. Intra-
gastric wedge resection requires special equipment that may not be
readily available at some centers and there remains a risk of tumor
seeding and gastric mucosal injury [3]. A major drawback of
extraluminal wedge resection is difﬁculty in determining the
appropriate resection line as it is impossible to ascertain with cer-
tainty the margins when the tumor is intraluminal [6].
Endoscopic submucosal dissection (ESD) has become an
acceptable modality for removal of benign and malignant gastric
tumors with excellent success rates and safety. Initially, it was
thought that endoscopic removal of gastric tumors arising from the
muscularis propria was contraindicated due to a high risk of
perforation and bleeding [1,7]. However, subsequent studies in
small numbers of adults have shown that, in experienced hands,
gastric tumors arising from the muscularis propria layer can be
successfully removed (75%e90%) with low rates of bleeding (0%e
10%) and perforation (0%e10%) [8,9]. An important limitation of
ESD is that complete resection relies solely on endoscopic obser-
vation; it is difﬁcult to achieve complete histological resection of
tumors related to an inability to obtain sufﬁcient margins during
endoscopy [8]. In a study assessing endoscopic mucosal resection of
early gastric cancers nearly 17% had incomplete resection [10].
EALS for gastric tumors was ﬁrst introduced in 1999 by Aogi
et al. [11]. Initially, endoscopy was used primarily as an “extra set of
eyes” allowing better localizing of the tumor [11e21]; recent
studies have combined ESD with LS with excellent results [22,23].
Beneﬁts of a combined approach include better localization of the
tumor, determining the best laparoscopic approach, verifying
complete resection, ensuring adequate margins, and assuring leak-
proof suture lines [22,23]. In the present case, endoscopy conﬁrmed
that the tumor was localized to the gastric body in a location
accessible for laparoscopic removal. Biopsy forceps were then used
to show the surgeons the location by pressing on the tumor and
“tenting” the gastric wall for laparoscopic visualization. Endoscopic
visualization during placement of the gastric stapler conﬁrmed that
the entire tumor was captured and that the gastric lumen would
not be impeded once the tumor was removed. Finally, after resec-
tion the stomach was gently insufﬂated to ensure that the suture
line was leak-proof.
The ﬁnding of a gastric neuroﬁbroma is exceedingly rare,
particularly in children. Neuroﬁbromas account for 0.1% of gastric
tumors foundat autopsy [24] and0.06%of surgically removedgastric
tumors [25]. Of individuals with gastrointestinal neuroﬁbromas,
15%e17% have neuroﬁbromatosis (von Recklinghausen disease),
while the remainder (83%e85%) have an isolated neuroﬁbroma
[26,27]. It has been estimated that 25% of individuals with neuroﬁ-
bromatosis develop gastrointestinal neuroﬁbromas [28]. The dis-
tribution of neuroﬁbromas differs between individuals with
neuroﬁbromatosis and those with isolated neuroﬁbromas. In
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followed by stomach, ileum, duodenum, and colon [27]. For isolated
neuroﬁbromas the ileum is the most commonly involved site, fol-
lowed by the jejunum, duodenum, and stomach [29]. Within the
stomach, the antrum is the most commonly involved site (39%),
followed by the posterior wall (16%), lesser curvature (13%), fundus
(10%), body (10%), greater curvature (6%), and anteriorwall (6%) [26].
Presentation of gastrointestinal neuroﬁbromas depends on where
the tumors arise. Most arise from the submucosal myogenic (Auer-
bach’s) plexus, leading to subserosal lesions, which tend to present
with obstruction due to external compression or volvulus [30].
Neuroﬁbromas can also arise from the submucosal (Meissner’s)
plexus, which protrude into the lumen. These lesions may be found
incidentally at endoscopy, or present with abdominal pain, anemia,
gastrointestinal bleeding, or vomiting [26,30]. The deﬁnitive diag-
nosis of neuroﬁbroma is dependent on microscopic examination.
Neuroﬁbromas of the gastrointestinal tract are histologically iden-
tical to those thatoccur in extraintestinal locations, showingbundles
of proliferating wavy, hyperchromatic spindle cells admixed with
collagen, scattered neuritis, and variable degrees of myxoid matrix
[31]. Themain differential diagnosis is schwannoma, another benign
peripheral nerve sheath tumor. Both neuroﬁbromas and schwan-
nomas show some S100 immunohistochemical reactivity. However,
schwannomas are typically encapsulated with a distinctive combi-
nation of Antoni A and B growth patterns. Neuroﬁbromas, on the
other hand, are usually not encapsulated and show a range of cell
types, including Schwann cells and ﬁbroblasts [32]. Other lesions in
the differential diagnosis include leiomyoma (a benign smooth
muscle tumor typically positive fordesminandother smoothmuscle
markers) and GIST (a spindle cell tumor recapitulating the intersti-
tial cells of Cajal, typically positive for CD117 and CD34).
3. Conclusion
We report the successful use of EALS for the removal of a sub-
mucosal gastric neuroﬁbroma in a child. We present this case to
highlight the feasibility of a combined surgical-endoscopic approach
to submucosal gastric tumors in children. Also, we provide a litera-
ture review of gastric neuroﬁbromas, a rare ﬁnding in children.
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